LANDP Q1 2026 Earnings Preferred EPS Beats Estimates Despite Negative Earnings SRTA Q1 2026 Earnings Strong EPS Surprise Signals Turnaround Momentum XOMA Royalty Corporation Q1 2026 Earnings EPS Misses Estimates Royalty Revenues Under Scrutiny InMed Pharmaceuticals Q3 2025 Earnings Continued Losses as Stock Declines LMRI Q1 2026 Earnings EPS Surges Past Estimates Signaling Strong Operational Momentum Workhorse Group Q1 2026 Earnings EPS Miss Widens as Company Remains PreRevenue